Semus Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,293
Closed -$339K 122
2024
Q2
$339K Sell
8,293
-2,638
-24% -$105K 0.26% 72
2024
Q1
$453K Sell
10,931
-814
-7% -$34.1K 0.38% 59
2023
Q4
$475K Sell
11,745
-592
-5% -$22.6K 0.39% 58
2023
Q3
$483K Sell
12,337
-833
-6% -$33.2K 0.45% 52
2023
Q2
$535K Hold
13,170
0.49% 49
2023
Q1
$551K Sell
13,170
-53
-0.4% -$2.23K 0.59% 41
2022
Q4
$576K Buy
+13,223
New +$562K 0.7% 39

Other funds holding BME

Semus Wealth Partners's BME Position: Q3 2024 in Review

Semus Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q3 2024, closing a stake of 8,293 shares — an estimated $339K sold.

Semus Wealth Partners first reported a position in BME in Q4 2022 and held it in 7 quarters. The position peaked at $576K in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

  • Semus Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q3 2024 after selling out during the quarter.
  • Semus Wealth Partners sold 8,293 BlackRock Health Sciences Trust shares in Q3 2024, an estimated $339K.
  • Semus Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 7 quarters.
  • Semus Wealth Partners's BlackRock Health Sciences Trust position peaked at $576K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Semus Wealth Partners's 13F filing for Q3 2024, filed 7 Nov 2024.